Highlights
NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
76.98   -4.70 (5.75%)  76.90 - 83.00  268,400

Overview

 
Avg Volume (4 weeks):185,311
4 Weeks Range:76.90 - 92.94
4 Weeks Price Volatility (%):
0.50%
52 Weeks Range:76.90 - 148.18
52 Weeks Price Volatility (%):
0.11%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers